Literature DB >> 16427380

Surgery in hemophilia. The general view: patient selection, timing, and preoperative assessment.

Jørgen Ingerslev1, Ivan Hvid.   

Abstract

Although often overlooked, the life of the patient with severe hemophilia is characterized by both intermittent and chronic pain. Bleeds into joints and muscles cause extensive pressure on sensory nerves and, following recurrent bleeds, joint destruction, and synovial reaction is accompanied by constant pains that are frequently mistaken for further bleeding. The orthopedic surgeon may break the vicious cycle of chronic synovitis by excising inflamed and hypertrophic synovium or severely damaged cartilage and adjacent bone ends, and implanting an artificial joint. Numerous technical solutions are now available and orthopedic surgery is increasingly on offer to those hemophilia patients who, since childhood, have been victims of insufficiently treated bleeds because no or limited treatment was available, and because the concept of prophylaxis had not yet been developed. Nonetheless, orthopedic surgery in patients with hemophilia requires much more effort and planning than surgery in non-hemophilic patients. In this overview, we will address issues related to surgery in hemophilic patients, as well as some practical issues related to the timing of surgery, preoperative testing, perioperative hemostasis, and patient rehabilitation.

Entities:  

Mesh:

Year:  2006        PMID: 16427380     DOI: 10.1053/j.seminhematol.2005.11.024

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  4 in total

1.  Urological surgery in patients with hemorrhagic bleeding disorders Hemophilia A, Hemophilia B, von Willebrand disease: a retrospective study with matched pairs analysis.

Authors:  Sebastian Rogenhofer; Stefan Hauser; Anne Breuer; Guido Fechner; Stefan C Mueller; Johannes Oldenburg; Georg Goldmann
Journal:  World J Urol       Date:  2012-11-21       Impact factor: 4.226

2.  Safety and efficacy of turoctocog alfa (NovoEight®) during surgery in patients with haemophilia A: results from the multinational guardian™ clinical trials.

Authors:  E Santagostino; S R Lentz; M Misgav; B Brand; P Chowdary; A Savic; Y Kilinc; Y Amit; A Amendola; L P Solimeno; T Saugstrup; I Matytsina
Journal:  Haemophilia       Date:  2014-10-02       Impact factor: 4.287

3.  Totally extraperitoneal inguinal hernia repair in patients with hemophilia and von Willebrand disease. Prospective controlled study.

Authors:  Konrad Pielaciński; Bartosz Puła; Andrzej B Szczepanik
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2021-02-26       Impact factor: 1.195

4.  Risk Factors for Amputation in the Surgical Treatment of Hemophilic Osteoarthropathy: A 20-Year Single-Center Report.

Authors:  Yiming Xu; Bin Feng; Wei Zhu; Yingjie Wang; Xisheng Weng
Journal:  Pain Res Manag       Date:  2022-03-28       Impact factor: 3.037

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.